Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
01 2Midas Pharma
02 1LGM Pharma
03 1Cohance Lifesciences
04 1Chemische Fabrik Berg
05 1DKSH
06 1Dr. Reddy's Laboratories
07 1Jai Radhe Sales
08 1Moehs Iberica
09 1HRV Global Life Sciences
10 1Zeon Pharma Industries India Pvt Ltd
11 1Almelo
12 1Apotex Pharmachem
13 1Aurobindo Pharma Limited
14 1BASF Corp
15 1CHEMO
16 1Cilag AG
17 1Cipla
18 1DEAFARMA
19 1Daito Pharmaceutical
20 1Fareva
21 1Guangzhou Tosun Pharmaceutical
22 2Nifty Labs
23 1Nosch Labs Pvt
24 1Permachem
25 1Permachem Asia, Ltd
26 1Saneca Pharmaceuticals
27 1Srini Pharmaceuticals
28 1Standard Chem. & Pharm. Co., Ltd
29 1Synergene Active Ingredients Pvt Ltd
30 1Therapiva
31 1Unichem Laboratories Limited
32 1Unipex
33 1Wockhardt
34 1Zhejiang Lepu Pharmaceutical
35 1Zhejiang Neo-Dankong Pharm. Co.,Ltd.
36 1Blank
01 1Canada
02 4China
03 1France
04 3Germany
05 16India
06 1Italy
07 3Japan
08 1Luxembourg
09 1Slovakia
10 2Spain
11 2Switzerland
12 1U.S.A
13 2Blank
01 6Active
02 6Inactive
03 26Blank
01 9Valid
02 29Blank
01 1217MF10662
02 1217MF11138
03 1218MF10433
04 1218MF10823
05 1218MF10903
06 1228MF10017
07 1305MF10107
08 31Blank
01 1WC-0026
02 1WC-0027
03 1WC-0120
04 1WC-0150
05 1WC-0313
06 1WC-0316n
07 1WC-316
08 31Blank
Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
Certificate Number : CEP 2024-112 - Rev 00
Issue Date : 2024-08-05
Type : Chemical
Substance Number : 2125
Status : Valid
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-12-31
Pay. Date : 2019-12-23
DMF Number : 22941
Submission : 2009-07-10
Status : Active
Type : II
Certificate Number : CEP 2010-312 - Rev 03
Issue Date : 2023-10-27
Type : Chemical
Substance Number : 2125
Status : Valid
Date of Issue : 2022-07-07
Valid Till : 2025-07-21
Written Confirmation Number : WC-0150
Address of the Firm :
NDC Package Code : 17511-113
Start Marketing Date : 2009-07-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Available Reg Filing : CN, RU |
Certificate Number : CEP 2022-316 - Rev 00
Issue Date : 2024-04-29
Type : Chemical
Substance Number : 2125
Status : Valid
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-08-28
Pay. Date : 2023-03-08
DMF Number : 12750
Submission : 1997-11-14
Status : Active
Type : II
Certificate Number : R1-CEP 2008-164 - Rev 05
Issue Date : 2023-05-15
Type : Chemical
Substance Number : 2125
Status : Valid
NDC Package Code : 55111-005
Start Marketing Date : 1999-11-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
We have 35 companies offering Doxazosin Mesylate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?